Glenmark Pharmaceuticals gets go-ahead to conduct trials with ‘favipiravir’ on COVID-19 patients
Bangalore: Glenmark Pharmaceuticals Ltd said Thursday it will start clinical trials in India of antiviral drug ‘favipiravir’. It is being seen as a potential treatment for COVID-19 patients. The trials come after a Chinese official told reporters last month about the drug’s success. The official...











































